Usage of Tranexamic Acid for Treatment of Subdural Hematomas

Michael Wu, Hassaan Wajeeh, Marissa N McPhail, Omar Seyam, Jamie Flora, Hoang Nguyen, Michael Wu, Hassaan Wajeeh, Marissa N McPhail, Omar Seyam, Jamie Flora, Hoang Nguyen

Abstract

The collection of blood in the subdural layer within the cranium is classified as a subdural hematoma. Prevalence of subdural hematomas is most common among older populations with the current standard of treatment being invasive surgical evacuation for patients presenting with acute subdural hematomas with a midline shift greater than 5 mm on computed tomography (CT).Tranexamic acid (TXA) has been identified as an alternative, non-invasive option to treat patients presenting with subdural hematoma who are not suitable for surgical intervention. The presenting case involves a 90-year-old female who arrived with a code stroke with the chief complaint of right lower extremity weakness. A stroke series CT panel revealed a left frontal multiloculated subdural hematoma, measuring 130 mL with mass effect and a midline shift of 7 mm. The patient was recommended a craniotomy for hematoma evacuation or access to hospice for comfort care. A second opinion resulted in the administration of TXA. After the full completion of a TXA course, the patient achieved baseline mobility. The final measurements revealed a final hematoma volume of 10 mL and a midline shift of less than 2 mm. Current literature, as well as the case described, has begun demonstrating the efficacy of the usage of TXA in the reabsorption of subdural hematomas and should encourage further exploration into society guidelines for the usage of TXA as a non-invasive alternative to treat subdural hematomas.

Keywords: chronic subdural hematoma (csdh); middle meningeal artery embolization; open craniotomy; subdural hematoma (sdh); tranexamic acid.

Conflict of interest statement

The patient described in the case report is an immediate family member of the principal investigator.

Copyright © 2023, Wu et al.

Figures

Figure 1. Initial CT scan displaying the…
Figure 1. Initial CT scan displaying the 130 ml hematoma with concurrent 7 mm of midline shift
Figure 2. Initial CT scan displaying the…
Figure 2. Initial CT scan displaying the 130 ml hematoma with concurrent 7 mm of midline shift
Figure 3. Initial CT scan displaying the…
Figure 3. Initial CT scan displaying the 130 ml hematoma with concurrent 7 mm of midline shift
Figure 4. Final CT scan displaying final…
Figure 4. Final CT scan displaying final hematoma volume of 10 ml and less than 2 mm of midline shift
Figure 5. Final CT scan displaying final…
Figure 5. Final CT scan displaying final hematoma volume of 10 ml and less than 2 mm of midline shift

References

    1. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. Feghali J, Yang W, Huang J. World Neurosurg. 2020;141:339–345.
    1. Middle meningeal artery embolization as an adjuvant treatment to surgery for symptomatic chronic subdural hematoma: a pilot study assessing hematoma volume resorption. Ng S, Derraz I, Boetto J, et al. J Neurointerv Surg. 2020;12:695–699.
    1. Spontaneous resolution of chronic subdural hematoma: does only the size matter? Junior MG, Pessoa BL, Landeiro JA, de Abreu Macedo PH, Leite MA. Surg Neurol Int. 2019;10:194.
    1. Expanding subdural hematomas in the subacute stage and treatment via catheter drainage. Ha JH, Park JH, Jeong JH, Im SB, Hwang SC. Korean J Neurotrauma. 2018;14:76–79.
    1. Chronic subdural hematoma in an elderly patient: diagnosis and management overview in primary care setting. Wang AS. Proc UCLA Healthc. 2017;21
    1. Nonsurgical treatment of chronic subdural hematoma with tranexamic acid. Kageyama H, Toyooka T, Tsuzuki N, Oka K. J Neurosurg. 2013;119:332–337.
    1. Current diagnosis and treatment of chronic subdural haematomas . Iliescu I. J Med Life. 2015;8:278–284.
    1. Uses of tranexamic acid. Reed MR, Woolley LT. Anaesth Crit Care Pain Med. 2015;15:32–37.
    1. Tranexamic Acid in Chronic Subdural Hematomas (TRACS): study protocol for a randomized controlled trial. Iorio-Morin C, Blanchard J, Richer M, Mathieu D. Trials. 2016;17:235.
    1. Tranexamic acid to prevent operation in chronic subdural haematoma (TORCH): study protocol for a randomised placebo-controlled clinical trial. Immenga S, Lodewijkx R, Roos YB, et al. Trials. 2022;23:56.
    1. Surgical management of acute subdural hematomas. Bullock MR, Chesnut R, Ghajar J, et al. Neurosurgery. 2006;58:2–16.
    1. Middle meningeal artery embolization treatment of nonacute subdural hematomas in the elderly: a multiinstitutional experience of 151 cases. Joyce E, Bounajem MT, Scoville J, et al. Neurosurg Focus. 2020;49:0.
    1. The outcome of medical management of chronic subdural hematoma with tranexamic acid - a prospective observational study. Kutty RK, Leela SK, Sreemathyamma SB, Sivanandapanicker JL, Asher P, Peethambaran A, Prabhakar RB. J Stroke Cerebrovasc Dis. 2020;29:105273.
    1. Conservative treatment of chronic subdural hematoma in HIV-associated thrombocytopenia with tranexamic acid. Kutty RK, Peethambaran AK, Sunilkumar Sunilkumar, Anilkumar M. J Int Assoc Provid AIDS Care. 2017;16:211–214.

Source: PubMed

3
Suscribir